Market Tracker

01/21 5:16pm ET

Abbvie Inc (NYSE:ABBV)

132.01
Delayed Data
As of Jan 21
 -1.02 / -0.77%
Today’s Change
101.81
Today|||52-Week Range
138.15
-2.50%
Year-to-Date
Is AbbVie Stock a Top Pick for 2022?
6:12am / MotleyFool.com - Paid Partner Content
5 Reasons to Invest in Dividend Stocks for Retirement
Jan 19 / MotleyFool.com - Paid Partner Content
1 Top Dividend Stock to Buy Right Now
Jan 22 / MotleyFool.com - Paid Partner Content
3 Buy-Rated Stocks Yielding More than 4%
Jan 19 / StockNews.com - Paid Partner Content
3 Clinical Trials to Watch in the First Half of 2022
Jan 22 / MotleyFool.com - Paid Partner Content
Townsend & Associates, Inc Buys The AES Corp, ConocoPhillips, Huntsman Corp, Sells ...
Jan 18 / GuruFocus News - Paid Partner Content
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
Jan 22 / MotleyFool.com - Paid Partner Content
HealthInvest Partners AB Buys McKesson Corp, Cardinal Health Inc, AmerisourceBergen Corp, Sells ...
Jan 18 / GuruFocus News - Paid Partner Content
Sequent Asset Management, LLC Buys ALPS Clean Energy ETF, AbbVie Inc, Fidelity Nasdaq Composite ...
Jan 21 / GuruFocus News - Paid Partner Content
Private Wealth Group, LLC Buys SPDR Bloomberg 1-10 Year TIPS ETF, AbbVie Inc, Sells SPDR ...
Jan 18 / GuruFocus News - Paid Partner Content
International Assets Investment Management, Llc Buys Vanguard High Dividend Yield Indx ETF, ...
Jan 21 / GuruFocus News - Paid Partner Content
Zacks Industry Outlook Highlights: Roche, Pfizer, AbbVie and Merck
Jan 18 / Zacks.com - Paid Partner Content
4 Stocks to Buy if You Think Inflation is Peaking
Jan 21 / StockNews.com - Paid Partner Content
AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know
Jan 17 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: GSK's Consumer Unit Offer Rejection, FDA Updates for AZN, PFE
Jan 21 / Zacks.com - Paid Partner Content
AbbVie's (ABBV) Rinvoq Gets FDA Nod for Atopic Dermatitis
Jan 17 / Zacks.com - Paid Partner Content
J&J (JNJ) to Set the Stage for Pharma Sector Q4 Earnings
Jan 21 / Zacks.com - Paid Partner Content
Pfizer's (PFE) Cibinqo Gets FDA Nod for Atopic Dermatitis
Jan 17 / Zacks.com - Paid Partner Content
Zacks Value Trader Highlights: AbbVie, The Andersons and Ingredion
Jan 21 / Zacks.com - Paid Partner Content
4 Large-Cap Drugmaker Stocks to Watch Despite Omicron Woes
Jan 17 / Zacks.com - Paid Partner Content
Columbus Macro, LLC Buys SPDR Portfolio Short Term Corporate Bond ETF, PowerShares QQQ Trust ...
Jan 21 / GuruFocus News - Paid Partner Content
The Zacks Analyst Blog Highlights: Pfizer (PFE), Beam Therapeutics, AbbVie, Merck and Glaxo
Jan 17 / Zacks.com - Paid Partner Content
Peavine Capital, Llc Buys Abbott Laboratories, The Home Depot Inc, McDonald's Corp
Jan 21 / GuruFocus News - Paid Partner Content
Is AbbVie a Good Dividend Stock to Buy Right Now?
Jan 17 / MotleyFool.com - Paid Partner Content
Sabal Trust CO Buys AbbVie Inc, Best Buy Co Inc, WEC Energy Group Inc, Sells Bristol-Myers ...
Jan 21 / GuruFocus News - Paid Partner Content
3 Pharma Stocks With Especially Juicy Dividends
Jan 16 / MotleyFool.com - Paid Partner Content
Encompass Wealth Advisors, Llc Buys AbbVie Inc, Coca-Cola Co, Freeport-McMoRan Inc, Sells Tesla ...
Jan 20 / GuruFocus News - Paid Partner Content
Pharma Stock Roundup: PFE's Research Deal With BEAM & Other Updates
Jan 14 / Zacks.com - Paid Partner Content
M. Kulyk & Associates, LLC Buys The Walt Disney Co, American Express Co, Coca-Cola Co, ...
Jan 20 / GuruFocus News - Paid Partner Content
Pfizer's (PFE) Prevnar 20 Plus COVID Vaccine Study Succeeds
Jan 13 / Zacks.com - Paid Partner Content
3 Value Stocks Breaking out in 2022
Jan 20 / Zacks.com - Paid Partner Content
4 Top Dividend Payers of the S&P 500
Jan 13 / MotleyFool.com - Paid Partner Content
Kinloch Capital, LLC Buys Vanguard Consumer Discretionary ETF, Clorox Co, JPMorgan Ultra-Short ...
Jan 20 / GuruFocus News - Paid Partner Content
Does Johnson & Johnson's Split Make Sense?
Jan 12 / MotleyFool.com - Paid Partner Content
Strategic Capital Advisers, Inc. Buys Archer-Daniels Midland Co, AbbVie Inc, SPDR S&P ...
Jan 19 / GuruFocus News - Paid Partner Content
2 Monster Stocks to Buy for 2022 That Are Practically Minting Money
Jan 12 / MotleyFool.com - Paid Partner Content
Swarthmore Group Inc Buys AbbVie Inc, Pfizer Inc, Cboe Global Markets Inc, Sells Stryker Corp, ...
Jan 19 / GuruFocus News - Paid Partner Content
Merck (MRK) Keytruda Betters Survival in Adjuvant Lung Cancer
Jan 11 / Zacks.com - Paid Partner Content
2 Best Warren Buffett Dividend Stocks to Buy Now
Jan 19 / MotleyFool.com - Paid Partner Content
Pfizer (PFE) Partners Beam Therapeutics for Rare Disease Drugs
Jan 11 / Zacks.com - Paid Partner Content
3 Under-the-Radar COVID Stocks
Jan 19 / MotleyFool.com - Paid Partner Content
AbbVie (ABBV) Gains As Market Dips: What You Should Know
Jan 10 / Zacks.com - Paid Partner Content
Profit Investment Management, LLC Buys Patterson Inc, Vanda Pharmaceuticals Inc, Plantronics ...
Jan 19 / GuruFocus News - Paid Partner Content
AstraZeneca (AZN) Inks Deal to Develop ATTR-CM Candidate
Jan 10 / Zacks.com - Paid Partner Content
Asymmetry Capital Management, L.P. Buys Biomarin Pharmaceutical Inc, UnitedHealth Group Inc, ...
Jan 19 / GuruFocus News - Paid Partner Content
Sanofi (SNY) Inks Deal to Develop AI-Driven Precision Medicines
Jan 10 / Zacks.com - Paid Partner Content
Arkansas Financial Group, Inc. Buys iShares U.S. ...
Jan 19 / GuruFocus News - Paid Partner Content
The Zacks Analyst Blog Highlights: Pfizer, AbbVie, Eli Lilly and J&J
Jan 10 / Zacks.com - Paid Partner Content